跳至主要内容
临床试验/CTRI/2017/07/009136
CTRI/2017/07/009136已完成未知

Effect of Vitamin D supplementation in treatment of First Episode Psychosis: A Randomised double blind, placebo controlled study

Central Institute of Psychiatry0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Either sex.
  • 2. Age: 18-45 years.
  • 3. Diagnosed cases of a. Schizophrenia (all subtypes) b. Mania with psychotic symptoms c. Severe Depression with psychotic symptoms d. Acute & Transient Psychotic Disorder ; fulfilling ICD-10 DCR (WHO, 1993) criteria.
  • 4. Status of patient should be drug naïve (or drug free for minimum 4 weeks for oral psychotropic medications & 8 weeks for depot preparations).
  • 5. Patients giving written informed consent.

排除标准

  • 1. Presence of co-morbid psychiatric disorder. 2. Individuals with history of substance use meeting dependence criteria, other than nicotine & caffiene.
  • 3. Co-morbid medical illness known to affect Vit.D level (Arthritis, Osteoporosis, Rickets, End Stage Renal Disease, Malabsorption Syndromes, Corticosteroid therapy).
  • 4. Patients already on Vitamin D supplementation.
  • 5. Patients receiving anticonvulsant medications as mood stabilizer.
  • 6. Patients with BMI more than 30kg/m².
  • 7. Menopausal females.

研究者

相似试验